September 8, 2021
Image credit: ppat.1009917
09/09/2021
Review
Culyba & Van Tyne review recent advances in the study of within-host bacterial evolution during human infection and discuss practical considerations for conducting such studies.
Image credit: ppat.1009872
Current Issue August 2021
09/03/2021
Pearls
In this Pearls article, Kumar, Chandele & Sharma summarize the current status of mAb-based therapy for COVID-19 and shed light on the ongoing development of mAbs-based therapeutics against emerging SARS-CoV-2 variants.
Image credit: ppat.1009885
09/02/2021
Opinion
In this Opinion, Kremer discusses the characteristics that make adenoviruses a risk, including efficient intra- and interspecies transmission, thermostable particles, persistent/latent infections in diverse hosts, and the ability to readily recombine and escape herd immunity.
Image credit: ppat.1009814
09/09/2021
Research Article
Findings from Attinder Chadha and colleagues unravel a unique outside-in strategy employed by Entamoeba histolytica to inhibit NF-κB signaling from macrophages by targeting cullins.
Image credit: ppat.1009936
09/09/2021
Research Article
Brian C. Russo and colleagues demonstrate that actin polymerization is necessary to convert T3SS pores into an open conformation that is competent for virulence protein delivery.
Image credit: ppat.1009932
09/09/2021
Research Article
Adam Pickard and colleagues evaluate a range of human cell types for their ability to be infected and support replication of the SARS-CoV-2, and perform a screen of 1971 FDA-approved drugs to identify candidates for drug repurposing for treatment of COVID-19.
Image credit: ppat.1009840
09/07/2021
Research Article
From Chaintoutis, Thomou and colleagues.
Image credit: ppat.1009883
09/07/2021
Research Article
From Markosyan and colleagues.
Image credit: ppat.1009488
09/03/2021
Research Article
From Li, Lidsky, Xiao and colleagues.
Image credit: ppat.1009898
09/02/2021
Research Article
From Ganti and colleagues.
Image credit: ppat.1009321
Connect with Us